Header cover image

Commercial Services Healthcare Sector

Results

2305

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2305 companies

Fuse Medical

Market Cap: US$4.4m

Manufactures and distributes medical devices in the United States.

FZMD

US$0.061

7D

0%

1Y

-25.7%

Mitesco

Market Cap: US$4.4m

Engages in providing cloud computing, application hosting, and other data center related applications.

MITI

US$0.25

7D

-35.2%

1Y

-7.4%

Bounce Mobile Systems

Market Cap: US$4.4m

Delex Healthcare Group, Inc. engages in the development and distribution of pharmaceutical and healthcare products in Asia and the Philippines.

BNCM

US$0.0073

7D

-1.4%

1Y

n/a

Visionflex Group

Market Cap: AU$6.7m

Together its subsidiaries, engages in the provision of healthcare and corporate online search and appointment booking services in Australia.

VFX

AU$0.002

7D

0%

1Y

-60.0%

Raphael Pharmaceutical

Market Cap: US$4.4m

A pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids.

RAPH

US$0.22

7D

0%

1Y

-85.6%

AVVAA World Health Care Products

Market Cap: US$4.3m

Provides natural and therapeutic skin care products worldwide.

AVVH

US$0.0033

7D

23.6%

1Y

153.8%

Aoxing Pharmaceutical Company

Market Cap: US$4.3m

A specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People’s Republic of China.

AOXG

US$0.011

7D

50.0%

1Y

185.0%

Nu-Med Plus

Market Cap: US$4.3m

A medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide.

NUMD

US$0.052

7D

4.0%

1Y

4.0%

Virax Biolabs Group

Market Cap: US$4.3m

A biotechnology company, distributes, markets, and sells diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology.

VRAX

US$1.02

7D

-5.6%

1Y

13.3%

Indiva

Market Cap: CA$5.9m

Engages in the production, processing, and sale of cannabis and cannabis related products in Canada.

NDVA.H

CA$0.03

7D

0%

1Y

-45.5%

Quest PharmaTech

Market Cap: CA$5.9m

A pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer.

QPT

CA$0.035

7D

0%

1Y

16.7%

Azitra

Market Cap: US$4.3m

An early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases.

AZTR

US$0.29

7D

6.2%

1Y

-95.0%

KMA Holding

Market Cap: US$4.2m

Through its subsidiaries, manufactures human and pet home medical test kits and emergency response mobile hospital units in the United States.

MCDA

US$0.0001

7D

0%

1Y

n/a

Mustang Bio

Market Cap: US$4.2m

A clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases.

MBIO

US$1.25

7D

11.6%

1Y

-88.1%

Alaunos Therapeutics

Market Cap: US$4.2m

A clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders.

TCRT

US$2.66

7D

-6.3%

1Y

-76.9%

T2 Biosystems

Market Cap: US$4.2m

An in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally.

TTOO

US$0.16

7D

-3.8%

1Y

-96.8%

Titan Pharmaceuticals

Market Cap: US$4.2m

Does not have significant operations.

TTNP

US$4.37

7D

-6.5%

1Y

-32.0%

Celadon Pharmaceuticals

Market Cap: UK£3.1m

Engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines.

CEL

UK£0.045

7D

-10.0%

1Y

-95.5%

HeartSciences

Market Cap: US$4.2m

A medical technology company, focuses on applying AI-based technology to an ECG to enhance its clinical utility.

HSCS

US$3.96

7D

21.5%

1Y

-36.1%

Oragenics

Market Cap: US$4.2m

A development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States.

OGEN

US$0.19

7D

-5.0%

1Y

-91.4%

Dermata Therapeutics

Market Cap: US$4.2m

A late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications.

DRMA

US$0.74

7D

-5.9%

1Y

-78.0%

Encision

Market Cap: US$4.2m

A medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States.

ECIA

US$0.35

7D

-2.8%

1Y

-30.0%

Verici Dx

Market Cap: UK£3.0m

Develops prognostic and diagnostic tests for kidney transplant patients.

VRCI

UK£0.013

7D

11.1%

1Y

-84.4%

Aclarion

Market Cap: US$4.1m

Operates as a healthcare technology company in the United States.

ACON

US$6.70

7D

-3.5%

1Y

-99.8%

Trellus Health

Market Cap: UK£3.0m

Provides digital chronic condition management solutions for employers and health plans.

TRLS

UK£0.018

7D

0%

1Y

12.1%

XORTX Therapeutics

Market Cap: CA$5.5m

A late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease.

XRTX

CA$1.31

7D

-9.0%

1Y

-62.6%

Sharps Technology

Market Cap: US$4.0m

A medical device and pharmaceutical packaging company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States.

STSS

US$4.05

7D

-11.4%

1Y

-99.7%

Nuwellis

Market Cap: US$4.0m

A medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy.

NUWE

US$0.93

7D

-1.4%

1Y

-89.4%

Invion

Market Cap: AU$6.2m

A clinical-stage life-sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia.

IVX

AU$0.08

7D

-15.8%

1Y

-84.0%

Zero Candida Technologies

Market Cap: CA$5.5m

A technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis.

ZCT

CA$0.28

7D

-15.2%

1Y

n/a

Rua Bioscience

Market Cap: NZ$6.7m

Engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally.

RUA

NZ$0.03

7D

7.1%

1Y

-57.1%

TrivarX

Market Cap: AU$6.2m

A health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.

TRI

AU$0.01

7D

-23.1%

1Y

-66.7%

Mosaic ImmunoEngineering

Market Cap: US$4.0m

A development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer.

CPMV

US$0.49

7D

-9.3%

1Y

16.3%

MindBio Therapeutics

Market Cap: CA$5.5m

Operates as a clinical stage drug development company in Australasia.

MBIO

CA$0.01

7D

0%

1Y

-80.0%

ATI Physical Therapy

Market Cap: US$4.0m

Operates as an outpatient physical therapy provider that provides outpatient rehabilitation and adjacent healthcare services through its clinics in the United States.

ATIP

US$0.90

7D

0%

1Y

-81.3%

PainReform

Market Cap: US$3.9m

A clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel.

PRFX

US$1.97

7D

3.1%

1Y

-88.3%

Page 43 of 65